Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2016 / Cilt: 26 - Sayı: 3

Characteristics of Acinetobacter baumanni isolated in respirato- ry samples of patients obtained in intensive care unit

Yoğun bakım ünitesinde solunum örneklerinde Acinetobacter baumanni üremesi saptanan hastaların özellikleri

Pages
228–232
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

On culture antibiograms, highest susceptibility to colistin polymyxin, tobramycin, gentamicin, imipenem, ciprofloxacin was noted.Conclusion: As a result, in our intensive care unit high rates of mortality due to Acinetobacter baumanni were detected.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To determine the characteristics of the patients with ısolated Acinetobacter baumannii in respiratory samples in state hospital intensive care unit between April 2009-December 2012.Methods: We retrospectively evaluated patients with ısolated Acinetobacter baumannii in respiratory samples in state hospital intensive care unit between April 2009-December 2012.
📊
Key Findings & Data:Results: During this period, Acinetobacter baumannii isolated in respiratory samples of 38 patients (female=16, male n=22).
💡
Conclusion & Impact:On culture antibiograms, highest susceptibility to colistin polymyxin, tobramycin, gentamicin, imipenem, ciprofloxacin was noted.Conclusion: As a result, in our intensive care unit high rates of mortality due to Acinetobacter baumanni were detected.
🔬Design:Research Article
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To determine the characteristics of the patients with ısolated Acinetobacter baumannii in respiratory samples in state hospital intensive care unit between April 2009-December 2012.Methods: We retrospectively evaluated patients with ısolated Acinetobacter baumannii in respiratory samples in state hospital intensive care unit between April 2009-December 2012. Results: During this period, Acinetobacter baumannii isolated in respiratory samples of 38 patients (female=16, male n=22). The mean age of the patients was 68.6±18.1 years, and mean duration of hospitalisation was 25.4±18.3 days. Acinetobacter baumannii could be isolated from the culture media of respiratory samples after an average of 13.4±9.4 days followin inoculation A total of 29 cases (76.3%) exited. The underlying diseases were evaluated, and most frequently hypertension, stroke, heart failure, diabetes and COPD were detected. Prior to antibiotic use, urinary catheter, mechanical ventilation, nasogastric tube, total parenteral nutrition, central venous catheter had been most frequently detected risk factors. APACHE 2 score of the patients at admission to the intensive care unit was 23.3±5.7. On culture antibiograms, highest susceptibility to colistin polymyxin, tobramycin, gentamicin, imipenem, ciprofloxacin was noted.Conclusion: As a result, in our intensive care unit high rates of mortality due to Acinetobacter baumanni were detected.

Özet

Amaç: Nisan 2009-Aralık 2012 yılları arasında devlet hastanesi yoğun bakım ünitesinde yatan ve solunum örneklerinde acinetobacter baumannii üremesi saptanan hastaların özelliklerini belirlemekYöntemler: Nisan 2009-Aralık 2012 yılları arasında devlet hastanesi yoğun bakım ünitesinde yatan ve solunum örneklerinde acinetobacter baumannii üremesi saptanan hastaların dosyaları retrospektif olarak değerlendirildi.Bulgular: Bu süre içinde 38 hastanın solunum örneklerinde acinetobacter baumannii üremesi saptandı (kadın=16, erkek n=22). Hastaların yaş ortalaması 68,6±18,1, ortalama hastanede yatış günü 25,4±18,3, solunum örneklerinde acinetobacter baumannii üreme günü 13,4±9,4'tü. Olgulardan 29'unun (%76,3) exitus olduğu saptandı. Altta yatan hastalıklar değerlendirildiğinde en sık hipertansiyon, SVH, kalp yetmezliği, diyabet ve KOAH saptandı. Risk faktörü olarak en sık öncesinde antibiyotik kullanımı, idrar sondası, mekanik ventilasyon, nazogastrik sonda, total parenteral nutrisyon, santral venöz katater saptandı. Olguların yoğun bakıma kabul APACHE 2 skoru 23,3±5,7 idi. Yapılan kültür antibiyogramlarında kolistin, polimiksin, tobramisin, gentamisin, imipenem ve siprofloksasine karşı duyarlılık en fazlaydı.Sonuç: Sonuç olarak, yoğun bakımımızda acinetobacter baumannii'ye bağlı mortalite yüksektir.

🔖

Cite This Article

ÖZDEMİR, L., ÖZDEMİR, B. (2016). Characteristics of Acinetobacter baumanni isolated in respirato- ry samples of patients obtained in intensive care unit. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 26 - Sayı: 3, 228–232. https://ajindex.com/articles/209869

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Towner KJ. Acinetobacter: an old friend, but a new enemy. J Hosp Infect 2009;73:355-363. http://dx.doi.org/10.1016/j.jhin.2009.03.032
  2. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006;42:692-699. http://dx.doi.org/10.1086/500202 Saltoğlu N. Acinetobacter baumannii infeksiyonları ve teda- visi, XIII. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi Antalya, 2007, s.204-207.
  3. Falagas ME, Rafailidis PI. Attributable mortality of Acinetobacter baumannii: no longer a controversial issue. Critical Care 2007;11:134. http://dx.doi.org/10.1186/cc5911
  4. Medina J, Formento C, Pontet J, Curbelo A, Bazet C, Gerez J et al. Prospective study of risk factors for ventilator- associated pneumonia caused by Acinetobacter species. J Crit Care 2007;22:18-27. http://dx.doi.org/10.1016/j.jcrc.2006.06.010
  5. Garnacho J, Sole-Violan J, Sa-Borges M, Diaz E, Rello J. Clinical impact of pneumonia caused by Acinetobacter bau- mannii in intubated patients: a matched cohort study. Crit Care Med 2003;31:2478-2482. http://dx.doi.org/10.1097/01.CCM.0000089936.09573.F3
  6. Şengül A, Şengül E, Barış SA, Hayırlıoğlu N. Ventilatörle İlişkili Çok İlaca Dirençli Acinetobacter Baumannii Pnömonisinde Mortalite İle İlişkili Faktörlerin Değerlendirilmesi. Kocaeli Tıp Dergisi 2013;1:1-6.
  7. Aygencel G, Dizbay M, Türkoğlu M. Mortality Risk Factors of Acinetobacter baumannii Infections in a Medical Intensive Care Unit: A 2-Year Survey. FLORA 2011;16:23-31.
  8. Fadda G, Spanu T, Ardito F, Taddei C, Santangelo R, Siddu A, et al. Antimicrobial resistance among non-fermentative Gram- negative bacilli isolated from the respiratory tracts of Italian inpatients:a 3-year surveillance study by the Italian Epidemiological Survey. Int J Antimicrob Agents 2004;23:254- 261. http://dx.doi.org/10.1016/j.ijantimicag.2003.07.017
  9. Giamarellou H, Antoniadou A, Kanellakopoulou K. Acinetobacter baumannii: A universal threat to public health? Int J Antimicrob Agents 2008;32:106-119. http://dx.doi.org/10.1016/j.ijantimicag.2008.02.013
  10. Karageorgopoulos DE, Falagas ME. Current control and tre- atment of multidrug-resistant Acinetobacter baumannii infec- tions. Lancet Infect Dis 2008;8:751-762 http://dx.doi.org/10.1016/S1473-3099(08)70279-2
  11. Grupper M, Sprecher H, Mashiach T, Finkelstein R. Attributable mortality of nosocomial Acinetobacter bactere- mia. Infect Control Hosp Epidemiol 2007;28:293-298. http://dx.doi.org/10.1086/512629
  12. Poutanen SM, Louie M, Sim